DC-specific deletion of LKB1 led to increased insulin resistance; increased proportions of hepatic regulatory T cells (Tregs) and Th17 cells; increased expression of Cd36 and fibrotic markers; worsened steatosis; and elevated triglyceride and cholesterol levels. This evidence concerns the gene STK11 and steatosis.